UK Stocks-Factors to watch on April 14



April 14 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening higher on Wednesday, with futures FFIc1 up 0.1%.

* EMA: The European medicines watchdog said on Tuesday it was aware of a decision by its U.S. counterpart to pause the administration of Johnson & Johnson's JNJ.N COVID-19 vaccine due to rare instances of blood clots.

* BREXIT: Britain's Financial Conduct Authority will undertake a root-and-branch review of the UK capital market following Brexit to help attract more foreign company listings, a senior regulator said on Tuesday.

* WHEAT IMPORTS: Britain's wheat imports slowed in February but are still running well above last season's pace, customs data showed on Tuesday.

* TESCO: Britain's biggest retailer Tesco Plc TSCO.L is set to name Thierry Garnier, the chief executive officer of Kingfisher Plc KGF.L , as its non-executive director, Sky News reported on Tuesday.

* VACCINES: A UK study into using different COVID-19 vaccines in two-dose inoculations is being expanded to include shots made by Moderna MRNA.O and Novavax NVAX.O , researchers said on Wednesday.

* GOLD: Gold prices steadied after gaining in early trade on Wednesday as weakness in the U.S. dollar due to higher inflation was countered by some firming in Treasury yields.

* OIL: Crude climbed on Wednesday after industry data showed U.S. oil inventories declined more than expected and OPEC raised its outlook for oil demand, but gains were capped by worries about the coronavirus and by rising supplies of the energy resource.

* British mid-caps ended higher on Tuesday and hovered near record levels as data showed the country's economy grew in February and Babcock International surged on its proposed restructuring plans.

* UK CORPORATE DIARY: Robert Walters

RWA.L

Q1 trading update

Tesco

TSCO.L

FY results

* For more on the factors affecting European stocks, please click on:

TODAY'S UK PAPERS

> Financial Times

> Other business headlines


Reporting by Shanima A in Bengaluru; Editing by Shailesh Kuber

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.